These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33792113)

  • 1. Level of phosphate diets effect on fibroblast growth factor-23 levels in chronic kidney disease subjects: A meta-analysis.
    Li Z; Hu M; Guo Y; Zhang L; Peng Y; Abdelrahim MEA; Jiang X
    Int J Clin Pract; 2021 Jul; 75(7):e14195. PubMed ID: 33792113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lower versus higher phosphate diets on fibroblast growth factor-23 levels in patients with chronic kidney disease: a systematic review and meta-analysis.
    Tsai WC; Wu HY; Peng YS; Hsu SP; Chiu YL; Chen HY; Yang JY; Ko MJ; Pai MF; Tu YK; Hung KY; Chien KL
    Nephrol Dial Transplant; 2018 Nov; 33(11):1977-1983. PubMed ID: 29420827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial.
    Sigrist M; Tang M; Beaulieu M; Espino-Hernandez G; Er L; Djurdjev O; Levin A
    Nephrol Dial Transplant; 2013 Jan; 28(1):161-9. PubMed ID: 23024219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered dietary salt intake for people with chronic kidney disease.
    McMahon EJ; Campbell KL; Bauer JD; Mudge DW
    Cochrane Database Syst Rev; 2015 Feb; (2):CD010070. PubMed ID: 25691262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study.
    Kim H; Park J; Nam KH; Jhee JH; Yun HR; Park JT; Han SH; Chung W; Oh KH; Park SK; Kim SW; Kang SW; Choi KH; Ahn C; Yoo TH
    Nephrol Dial Transplant; 2020 Mar; 35(3):438-446. PubMed ID: 30615179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
    Block GA; Fishbane S; Rodriguez M; Smits G; Shemesh S; Pergola PE; Wolf M; Chertow GM
    Am J Kidney Dis; 2015 May; 65(5):728-36. PubMed ID: 25468387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease.
    Geddes RF; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(6):1354-61. PubMed ID: 24010686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.
    Burnett SM; Gunawardene SC; Bringhurst FR; Jüppner H; Lee H; Finkelstein JS
    J Bone Miner Res; 2006 Aug; 21(8):1187-96. PubMed ID: 16869716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.
    Selamet U; Tighiouart H; Sarnak MJ; Beck G; Levey AS; Block G; Ix JH
    Kidney Int; 2016 Jan; 89(1):176-84. PubMed ID: 26422502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
    Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).
    Aniteli TM; de Siqueira FR; Dos Reis LM; Dominguez WV; de Oliveira EMC; Castelucci P; Moysés RMA; Jorgetti V
    Pflugers Arch; 2018 Apr; 470(4):623-632. PubMed ID: 29372301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
    Isakova T; Ix JH; Sprague SM; Raphael KL; Fried L; Gassman JJ; Raj D; Cheung AK; Kusek JW; Flessner MF; Wolf M; Block GA
    J Am Soc Nephrol; 2015 Oct; 26(10):2328-39. PubMed ID: 25967123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function.
    Thomas L; Xue J; Murali SK; Fenton RA; Dominguez Rieg JA; Rieg T
    J Am Soc Nephrol; 2019 Nov; 30(11):2128-2139. PubMed ID: 31409727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 and renal function among young and healthy individuals.
    Bernasconi R; Aeschbacher S; Blum S; Mongiat M; Girod M; Todd J; Estis J; Nolan N; Renz H; Risch L; Conen D; Risch M
    Clin Chem Lab Med; 2018 Aug; 56(9):1483-1489. PubMed ID: 29708879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.